EBITDA: Income before interest, taxes, depreciation and amortization.
HOOKIPA Pharma Inc. (HOOK) had EBITDA of $-94.14M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$20.13M |
|
$-81.58M |
|
-- |
|
$20.13M |
|
$117.82M |
|
$-97.69M |
|
$16.48M |
|
$-81.21M |
|
$-81.21M |
|
$-81.58M |
|
$-81.58M |
|
$-81.58M |
|
$-81.58M |
|
$-97.69M |
|
|
EBITDA |
$-94.14M |
9.45M |
|
9.45M |
|
$-8.60 |
|
$-8.60 |
|
| Balance Sheet Financials | |
$147.12M |
|
$7.74M |
|
$14.22M |
|
$161.34M |
|
$41.99M |
|
-- |
|
$29.49M |
|
$71.48M |
|
$89.86M |
|
$89.86M |
|
$89.86M |
|
9.90M |
|
| Cash Flow Statement Financials | |
$-57.52M |
|
$-4.16M |
|
$65.67M |
|
$113.44M |
|
$117.52M |
|
$4.08M |
|
$2.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.50 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-485.34% |
|
-485.34% |
|
-467.69% |
|
-403.46% |
|
-405.29% |
|
$-61.68M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
1.04 |
|
349.44 |
|
-90.79% |
|
-90.79% |
|
-50.56% |
|
-90.79% |
|
$9.08 |
|
$-6.53 |
|
$-6.09 |
|